SEVERANCE AGREEMENTSeverance Agreement • May 7th, 2020 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMay 7th, 2020 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into as of August 7, 2019 (the “Effective Date”) by and between Leslie Sloan, Ph.D. (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).